ACL Reconstruction With/Without LET for ACL Injury
(STABILITY 2 Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial seeks the best approach for ACL reconstruction (surgery to repair a torn knee ligament) in young, active individuals, particularly athletes. It compares different tissue grafts—from the patellar tendon or quadriceps tendon—and examines whether adding lateral extra-articular tenodesis (LET) improves stability and reduces re-injury. Eligible participants are young athletes with a confirmed ACL tear who engage in sports involving pivoting or quick direction changes. As an unphased trial, this study allows participants to contribute to innovative research that could improve surgical outcomes for athletes.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that these surgical techniques are safe for ACL reconstruction?
Research has shown that combining lateral extra-articular tenodesis (LET) with anterior cruciate ligament reconstruction (ACLR) generally carries a low risk of side effects. One study linked this combined approach to fewer instances of ligament re-tearing without significantly increasing other complications. The observed side effects were mild and uncommon, indicating the treatment's safety.
LET stabilizes the knee after an ACL injury, helping to prevent further injury. Studies have shown that patients tolerate this approach well, and it may reduce the need for additional surgery. This is encouraging for those considering this treatment to avoid future knee issues.12345Why are researchers excited about this trial?
Researchers are excited about these treatments for ACL injuries because they explore the addition of lateral extra-articular tenodesis (LET) to standard ACL reconstruction techniques. LET could potentially enhance knee stability and reduce the risk of re-injury compared to traditional methods that use either bone patellar tendon bone (BPTB) or quadriceps tendon (QT) grafts alone. By combining LET with these existing grafts, the hope is to improve long-term outcomes and provide a more robust repair for athletes and active individuals. This approach is particularly promising because it aims to address some of the limitations of current surgical options by offering enhanced support to the knee.
What evidence suggests that this trial's treatments could be effective for ACL injury?
This trial will compare ACL reconstruction (ACLR) with and without lateral extra-articular tenodesis (LET). Research has shown that adding LET to ACLR can reduce the likelihood of needing another ACL surgery. Specifically, studies found that patients who underwent both ACLR and LET experienced fewer repeat injuries than those who only had ACLR. This suggests that LET might enhance knee stability. Importantly, these studies did not find more complications with the inclusion of LET, making it a promising option for improving ACL reconstruction outcomes.35678
Who Is on the Research Team?
Dianne M Bryant, PhD
Principal Investigator
Western University, School of Physical Therapy & Department of Surgery
Volker Musahl, MD
Principal Investigator
University of Pittsburgh
Alan Getgood, MD
Principal Investigator
Fowler Kennedy Sport Medicine Clinic, Western University, Department of Surgery
James J Irrgang, PT PhD FAPTA
Principal Investigator
University of Pittsburgh
Are You a Good Fit for This Trial?
This trial is for young, active individuals aged 14-25 with a fully mature skeleton and an ACL-deficient knee. They must participate in sports that involve pivoting or have certain knee conditions like a pivot shift of grade 2+ or ligamentous laxity. People can't join if they've had previous ACL surgery, multiple ligament injuries needing surgery, inflammatory joint diseases, are pregnant, or cannot consent.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Surgery and Initial Recovery
Participants undergo ACL reconstruction surgery using BPTB or QT autograft with or without LET, followed by initial recovery
Rehabilitation
Participants follow a standardized rehabilitation protocol to regain knee function and strength
Follow-up
Participants are monitored for graft stability, function, and adverse events
What Are the Treatments Tested in This Trial?
Interventions
- Anterior cruciate ligament reconstruction (ACLR)
- Lateral extra-articular tenodesis (LET)
Anterior cruciate ligament reconstruction (ACLR) is already approved in European Union, United States, Canada for the following indications:
- Anterior cruciate ligament rupture
- Knee instability
- Anterior cruciate ligament rupture
- Knee instability
- Anterior cruciate ligament rupture
- Knee instability
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pittsburgh
Lead Sponsor
University of Western Ontario, Canada
Collaborator
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Collaborator
Canadian Institutes of Health Research (CIHR)
Collaborator